help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 15, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-0079
This Article
Right arrow Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Sakharova, A. A
Right arrow Articles by Barkan, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakharova, A. A
Right arrow Articles by Barkan, A.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Metabolism
Right arrow Neuroendocrinology and Pituitary
Right arrow Lipid

Submitted on January 11, 2008
Accepted on April 7, 2008

ROLE OF GROWTH HORMONE IN REGULATING LIPOLYSIS, PROTEOLYSIS, AND HEPATIC GLUCOSE PRODUCTION DURING FASTING

Alla A Sakharova MD, Jeffrey F Horowitz PhD, Sowmya Surya MBBS, Naila Goldenberg MD, Matthew P Harber PhD, Kathy Symons, and Ariel Barkan MD*

Division of Metabolism, Endocrinology and Diabetes, Division of Kinesiology, and the Department of Neurosurgery, University of Michigan Medical Center, and the Ann Arbor DVA Medical Center, Ann Arbor, Michigan 48109

* To whom correspondence should be addressed. E-mail: abarkan{at}umich.edu.

Context: Fasting is associated with suppressed insulin and augmented growth hormone (GH) secretion. The involvement of each mechanism in the regulation of fuel mobilization during fasting is unknown.

Objective: To ascertain the role of GH in the regulation of the rates of lipolysis, proteolysis, and hepatic glucose production (HGP) during the physiological daily feed/fast cycle and after 2 days of complete fasting, using a model of selective GH suppression by the administration of GH-releasing hormone receptor antagonist (GHRH-A).

Design and Setting: An open label in-patient study in the General Clinical Research Center at the University of Michigan.

Participants: Six healthy, non-obese volunteers.

Main Outcome Measures: 24h plasma GH concentration, rates of lipolysis and proteolysis and HGP using stable isotope techniques after an overnight fast and after 2 days of fasting.

Results: GHRH–A suppressed plasma GH by ~65% during the fed state (p=0.015), but did not alter the rates of lipolysis, proteolysis, or HGP. Fasting for 2 days suppressed plasma insulin concentration by ~80% and elevated plasma GH ~4-fold (both p<0.01). This was accompanied by a doubling in the rate of lipolysis, ~40% increase in proteolysis and ~30% decline in HGP (all p<0.05). Preventing the fasting-induced increase in GH with GHRH-A largely abolished the increase in the rate of lipolysis. GHRH-A also augmented the fasting-induced reduction in HGP, but did not alter proteolysis.

Conclusions: Endogenous GH plays very limited metabolic role during the daily feed/fast cycle but is essential for the increased lipolytic rate found with more prolonged fasting.


Key words: ketosis • starvation • GHRH antagonist • proteolysis • IGF-1







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society